Prothena | Crediti Commerciali





Crediti Commerciali Cambiamento Data
Acadia Pharmaceuticals USD 148.23M 8.79M 2025-12
Agios Pharmaceuticals USD 10.58M 5.55M 2025-12
Akebia Therapeutics USD 61.54M 27.17M 2025-03
ALKERMES USD 334.02M 21.08M 2025-12
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
Amgen USD 9.57B 1.08B 2025-12
Biogen USD 1.85B 234M 2025-09
BioMarin Pharmaceutical USD 908.21M 117.95M 2025-12
Exelixis USD 286.92M 24.38M 2025-12
Immunic USD 1.5M 50K 2024-06
Incyte USD 1.02B 128.52M 2025-12
Ionis Pharmaceuticals USD 66M 41.39M 2025-12
MacroGenics USD 69.23M 56.7M 2025-09
Nektar Therapeutics USD 0 2.9M 2024-09
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
Prothena USD 5.16M 0 2023-12
Regeneron Pharmaceuticals USD 5.74B 54M 2025-12
Ultragenyx Pharmaceutical USD 112.54M 11.92M 2025-09
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12
Xoma USD 14.78M 4.96M 2024-06


Prothena Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2026.